Midkine Antagonists (Cellmid)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMidkine Antagonists (Cellmid)
Drug Alias NameMidkine Antagonists (Medical Therapies)midkine antagonists (Cell Signals)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamerSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionMidkine inhibitors
TargetsMidkine
Therapy Area/IndicationsMultiple SclerosisArthritis, RheumatoidNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCell Signals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCell Signals IncAnagenics Ltd
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisArthritis, RheumatoidNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A